Otsuka has sued the FDA and Abilify may not go generic. If this happens, does this affect the launch here? Don't be an ass in your responses. I only want to make sure I understand if this will have any implications in Alkermes' plans.
What if Abilify does not go generic?
Aucun commentaire:
Enregistrer un commentaire